Alida Biosciences Inc. — Form D
Alida Biosciences Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-17. The offering totals $8.5M, of which $7.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-06-17
- Form: D
- Accession: 0001870548-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.5M
- Amount sold: $7.5M
- Remaining: $1.0M
- Investors: 3
- Date of first sale: 2024-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-516210
Issuer
- Name: Alida Biosciences Inc.
- CIK: 0001870548
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 14813 PRISCILLA STREET, SAN DIEGO, CA, 92129
- Phone: 720-375-1071
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Paul Conley | Director | Washington, DC |
| John Drewry | Director | San Diego, CA |
| Landon Merrill | Director | San Diego, CA |
| Gudrun Stengel | Director | San Diego, CA |
| Gudrun Stengel | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More